🩺

Multiples Medical Devices Index

Curated by Multiples, this index tracks the largest medical device companies globally.

Explore the Multiples Medical Devices Index

100

public companies tracked

$4.5T

cumulative enterprise value

3.8x

median EV/NTM revenue multiple

8%

median NTM/LTM revenue growth

Index Performance

This chart shows the weighted market cap evolution over time for the Multiples Medical Devices Index constituents, indexed to 0% at the beginning of the period.

+41.2%

Multiples Medical Devices Index

Data as of 19 November 2026. Underlying financial data from FactSet and Morningstar. S&P 500 and NASDAQ data sourced from Yahoo Finance.

Key Index Metrics

This chart shows the median evolution over time of key valuation metrics for the Multiples Medical Devices Index constituents.

Valuation Benchmarks

This chart shows the regression relationship between valuation metrics across companies in the Multiples Medical Devices Index.

x-axis:
y-axis:

Data as of November 19, 2026. Companies with EV multiples above 50x and y-axis values above 250% are considered non-meaningful and excluded from calculation.

Company Rankings

This chart shows company rankings by selected metric within the Multiples Medical Devices Index.

Metric:

Data as of November 19, 2026. Companies with EV multiples above 50x and y-axis values above 300% are considered non-meaningful and excluded from calculation.

Companies Side-by-Side

Compare key metrics between companies in the Multiples Medical Devices Index.

1:
2:
3:
Metric
Samsung
Johnson & Johnson
Roche
Market Cap
$929B
$656B
$383B
EV/Revenue (NTM)
1.1x
6.4x
5.2x
EV/Gross Profit (NTM)
1.4x
8.9x
7.0x
EV/EBITDA (NTM)
1.6x
17.5x
12.9x
EV/FCF (NTM)
2.6x
26.6x
22.2x
Revenue Growth
46%
6%
4%
Gross Margin (NTM)
76%
72%
75%
EBITDA Margin (NTM)
65%
37%
41%
FCF Margin (NTM)
41%
24%
24%
Rule of 40
177%
44%
40%
Rule of X
353%
55%
40%

Data as of November 19, 2026.

Cumulative Metrics

This chart shows the cumulative sum of selected metrics across all companies in the Multiples Medical Devices Index, over time.

Index Methodology

Similar to the NASDAQ 100 Index, the Multiples Medical Devices Index employs a modified market capitalization weighting scheme.

The weight process uses company-level weights, which are derived using company market capitalization.

Company weights are evaluated based on two rules:

Rule 1

No company's weight may exceed 24%.

Rule 2

The aggregate weight of the companies whose weights exceed 4.5% may not exceed 48%.

If neither rule is 'violated', then no adjustments are made. Only in cases where either or both of the rules are 'violated', weight adjustments are made according to a two-stage adjustment process.

Rule 1 adjustment

If no company's initial weight exceeds 24% of the Index, initial weights are used as Rule 1 weights without adjustment. Otherwise, initial weights are adjusted such that no company's weight may exceed 20% of the Index.

Rule 2 adjustment

If the aggregate weight of the companies whose Rule 1 weights exceeds 4.5% and does not exceed 48%, Rule 1 weights are used as the final weights. Otherwise, Rule 1 weights are adjusted such that:

  • The aggregate weight of the companies whose Rule 1 weights exceeded 4.5% is set to 40%.
  • Companies with Rule 1 weights below 4.5% may also have their weights adjusted to keep the initial rank order of all companies.

If the two-stage rule process results in a 'violation' of the weighting rules as previously detailed, then the process is repeated until the company weights meet the rule system.

Companies Included in the Multiples Medical Devices Index

This index tracks the largest publicly listed medical device companies across diagnostics, surgical equipment, implantable technologies, and more.

KR
15.2%
$146
+113%
$929B
1.1x
46%
76%
65%
41%
177%
$2M
US
10.7%
$273
+32%
$656B
6.4x
6%
72%
37%
24%
44%
$682K
CH
6.2%
$480
+26%
$383B
5.2x
4%
75%
41%
24%
40%
$669K
US
4.2%
$693
+17%
$257B
5.8x
6%
43%
26%
17%
34%
$356K
DE
3.7%
$297
+12%
$227B
2.6x
8%
40%
18%
11%
23%
$288K
US
5.7%
$104
-19%
$181B
3.9x
8%
58%
27%
18%
39%
$385K
US
5.0%
$229
+1%
$161B
6.5x
8%
60%
32%
23%
39%
$409K
US
4.6%
$421
-27%
$146B
10.8x
13%
68%
46%
35%
65%
$591K
US
4.0%
$101
-4%
$129B
3.7x
5%
65%
28%
17%
33%
$383K
US
3.8%
$318
-14%
$121B
4.7x
7%
65%
29%
17%
35%
$449K
US
2.0%
$44
-57%
$63B
3.6x
0%
69%
31%
17%
36%
$340K
US
1.9%
$105
+21%
$61B
7.6x
10%
78%
32%
22%
44%
$379K
US
1.7%
$698
-7%
$55B
10.9x
9%
63%
36%
25%
46%
$391K
DE
1.7%
$48
-4%
$53B
1.8x
4%
37%
19%
8%
19%
$352K
US
1.6%
$177
+15%
$50B
6.5x
6%
55%
30%
21%
37%
$384K
US
1.4%
$466
+16%
$46B
7.2x
16%
56%
33%
23%
137%
$401K
US
1.2%
$84
+5%
$38B
2.0x
5%
41%
18%
9%
24%
$382K
CH
1.1%
$74
-6%
$36B
3.4x
6%
62%
27%
15%
30%
$401K
US
1.1%
$1,737
+18%
$35B
8.2x
5%
60%
32%
23%
38%
$222K
US
1.1%
$243
-14%
$34B
5.6x
4%
63%
39%
27%
40%
$497K
CN
1.1%
$28
-4%
$34B
5.4x
11%
60%
33%
29%
39%
$231K
US
1.0%
$210
+60%
$32B
6.7x
7%
69%
30%
23%
35%
$431K
US
1.0%
$83
+30%
$31B
5.3x
11%
64%
33%
22%
44%
$420K
NL
0.9%
$30
+6%
$29B
1.7x
3%
48%
18%
8%
19%
$293K
US
0.8%
$260
-3%
$25B
4.0x
7%
45%
29%
-
34%
$331K
DE
0.8%
$247
+3%
$24B
7.0x
10%
48%
32%
15%
36%
$318K
CH
0.6%
$346
+39%
$21B
4.2x
5%
75%
28%
18%
27%
$239K
US
0.6%
$103
+6%
$20B
3.0x
3%
72%
32%
15%
37%
$484K
US
0.6%
$647
+9%
$18B
5.9x
7%
30%
23%
21%
35%
$383K
GB
0.5%
$45
-5%
$17B
4.3x
11%
46%
26%
15%
37%
$377K
DK
0.5%
$74
-18%
$17B
4.3x
6%
66%
30%
16%
31%
$248K
NZ
0.5%
$27
+25%
$16B
10.3x
9%
67%
36%
21%
37%
$169K
US
0.5%
$86
+1%
$15B
2.3x
3%
57%
25%
9%
24%
$416K
CN
0.5%
$17
-7%
$14B
4.8x
19%
48%
17%
7%
36%
$253K
US
0.4%
$233
+119%
$14B
13.9x
31%
86%
13%
16%
70%
$464K
US
0.4%
$26
+40%
$14B
1.7x
2%
38%
18%
7%
23%
$300K
IN
0.4%
$13
+21%
$13B
3.8x
15%
73%
24%
11%
48%
$103K
GB
0.4%
$15
-8%
$13B
2.4x
5%
71%
26%
12%
30%
$355K
US
0.4%
$321
+9%
$13B
6.8x
14%
70%
18%
11%
31%
$299K
JP
0.4%
$11
-16%
$12B
1.9x
4%
66%
22%
6%
25%
$229K
US
0.4%
$164
+11%
$12B
2.5x
3%
72%
28%
20%
30%
$193K
US
0.4%
$61
-23%
$12B
3.2x
4%
67%
32%
15%
36%
$273K
DE
0.4%
$44
-9%
$11B
1.0x
2%
26%
17%
8%
17%
$197K
DK
0.3%
$51
+49%
$11B
3.2x
8%
78%
25%
12%
40%
$126K
US
0.3%
$370
+14%
$10B
3.7x
2%
54%
17%
13%
17%
$347K
US
0.3%
$140
-57%
$9.7B
2.8x
13%
73%
25%
14%
47%
$502K
US
0.3%
$63
+30%
$9.7B
3.1x
4%
52%
20%
5%
21%
$310K
US
0.3%
$71
-23%
$9.3B
2.7x
5%
71%
35%
24%
40%
$490K
JP
0.3%
$13
+40%
$8B
2.2x
7%
51%
21%
7%
27%
$276K
JP
0.2%
$27
-4%
$7.9B
1.9x
8%
45%
18%
2%
27%
$217K
CA
0.2%
$21
+30%
$7.5B
2.1x
6%
63%
21%
9%
26%
$392K
SE
0.2%
$27
+21%
$7.5B
2.3x
4%
50%
21%
10%
21%
$293K
CN
0.2%
$9
+11%
$7.3B
8.0x
14%
70%
46%
37%
57%
$242K
JP
0.2%
$27
+42%
$7B
6.4x
11%
71%
38%
20%
53%
$95K
CH
0.2%
$522
+27%
$6.9B
8.1x
3%
48%
45%
6%
38%
$316K
AU
0.2%
$103
-43%
$6.7B
4.1x
0%
72%
24%
15%
13%
$351K
US
0.2%
$166
+45%
$6.6B
3.3x
5%
62%
26%
19%
37%
$141K
SE
0.2%
$32
+7%
$6.3B
13.3x
16%
64%
27%
17%
33%
$270K
GB
0.2%
$3
+4%
$6.2B
2.9x
7%
60%
28%
13%
32%
$233K
CN
0.2%
$43
+31%
$6.1B
9.8x
26%
73%
40%
24%
66%
-
IN
0.2%
$273
-19%
$5.8B
6.5x
11%
47%
28%
23%
39%
$203K
US
0.2%
$123
+51%
$5.6B
4.2x
10%
61%
31%
24%
34%
$441K
US
0.2%
$19
-24%
$5.6B
4.3x
21%
67%
18%
6%
46%
$440K
US
0.2%
$95
+48%
$5.2B
3.1x
7%
69%
23%
9%
34%
$479K
US
0.2%
$86
-1%
$5.1B
3.2x
6%
53%
26%
16%
33%
$202K
JP
0.2%
$25
+13%
$5.1B
1.0x
3%
33%
12%
6%
13%
$204K
JP
0.2%
$117
+26%
$4.9B
1.5x
12%
45%
24%
9%
40%
$230K
US
0.1%
$17
-
$4.8B
1.3x
9%
58%
17%
3%
18%
$388K
GB
0.1%
$62
+35%
$4.5B
3.1x
16%
45%
26%
12%
42%
$201K
US
0.1%
$179
+20%
$4.5B
2.4x
4%
42%
20%
10%
18%
$172K
US
0.1%
$118
+4%
$4.5B
4.0x
15%
46%
26%
15%
40%
$327K
US
0.1%
$92
-30%
$4.4B
7.0x
28%
70%
17%
14%
67%
$428K
US
0.1%
$127
+76%
$4.3B
3.0x
2%
25%
23%
9%
19%
$163K
US
0.1%
$17
-33%
$4.3B
4.2x
9%
50%
26%
17%
49%
$282K
CN
0.1%
$4
-16%
$4.2B
2.9x
10%
51%
20%
21%
26%
$188K
CN
0.1%
$9
+46%
$4B
-
-
-
-
-
-
-
CN
0.1%
$13
-38%
$3.9B
8.6x
9%
91%
55%
45%
55%
$301K
US
0.1%
$24
+14%
$3.8B
1.4x
3%
56%
15%
10%
20%
$227K
JP
0.1%
$13
+24%
$3.7B
2.2x
6%
49%
21%
11%
31%
$202K
CH
0.1%
$282
+64%
$3.5B
3.1x
5%
35%
17%
8%
18%
$350K
DK
0.1%
$13
-3%
$3.4B
3.1x
11%
60%
21%
7%
24%
$190K
US
0.1%
$57
+99%
$3.4B
8.5x
28%
74%
14%
8%
42%
$362K
US
0.1%
$46
+235%
$3.4B
750.6x
153%
27%
-1941%
-1954%
-3459%
$3K
US
0.1%
$96
-34%
$3.3B
4.2x
18%
59%
22%
13%
49%
$674K
CN
0.1%
$6
+13%
$3.3B
4.3x
10%
66%
38%
22%
42%
$110K
IT
0.1%
$13
-18%
$3.3B
1.3x
25%
83%
24%
9%
25%
$175K
DE
0.1%
$38
-27%
$3.3B
1.4x
5%
51%
13%
5%
12%
$508K
CN
0.1%
$2
-21%
$3.3B
3.6x
10%
63%
32%
-
30%
$2M
CA
0.1%
$9
+38%
$3.3B
2.1x
0%
70%
37%
17%
45%
$506K
US
0.1%
$95
-50%
$3.2B
3.2x
20%
71%
15%
11%
35%
$311K
CN
0.1%
$8
-16%
$3.2B
5.2x
16%
56%
14%
11%
26%
-
US
0.1%
$9
+721%
$3.1B
364.8x
495%
52%
-305%
-301%
-1452%
-
US
0.1%
$55
+54%
$2.8B
4.1x
12%
76%
15%
6%
29%
$396K
DE
0.1%
$42
-51%
$2.7B
1.9x
5%
56%
27%
15%
33%
$178K
GB
0.1%
$3
+40%
$2.6B
6.0x
13%
64%
-5%
-11%
6%
$225K
DK
0.1%
$17
+8%
$2.5B
2.7x
-6%
41%
13%
7%
-32%
$319K
CH
0.1%
$125
-35%
$2.5B
3.1x
12%
63%
28%
3%
37%
$394K
CN
0.1%
$6
-13%
$2.5B
4.5x
14%
72%
29%
-
46%
-
CN
0.1%
$3
+4%
$2.4B
6.4x
13%
78%
47%
-
51%
-
US
0.1%
$306
+35%
$2.4B
3.5x
7%
29%
21%
11%
30%
$113K

Explore More Indexes

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial